A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder

References

• MasandPSTolerability and adherence issues in antidepressant therapyClin Ther20032582289230414512135
   PubMed Web of Science ®Google Scholar
• HowlandRHSequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomesJ Psychosoc Nurs Ment Health Serv200846102124
   Web of Science ®Google Scholar
• AstraZeneca Pharmaceuticals (Ireland)Seroquel XR: summary of product characteristics for Ireland2013 Available from: http://www.medicines.ie/medicine/13032/SPCAccessed August 1, 2013
   Google Scholar
• AstraZeneca PharmaceuticalsOnce-daily Seroquel XR (quetiapine fumarate) extended-release tablets2012 Available from: http://www1.astrazeneca-us.com/pi/seroquelxr.pdfAccessed July 9, 2012
   Google Scholar
• AstraZeneca PharmaceuticalsSeroquel XR product monograph (Canada)2011 Available from: http://www.astrazeneca.ca/documents/ProductPortfolio/SEROQUEL%20XR_PM_en.pdfAccessed July 21, 2011
   Google Scholar
• AstraZeneca PharmaceuticalsSeroquel XR Australian prescribing information2013 Available from: http://www1.astrazeneca-australia.com/pi/seroquelxr.pdf Accessed
   Google Scholar
• BortnickBEl-KhaliliNBanovMEfficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized studyJ Affect Disord20111281–2839420691481
   PubMed Web of Science ®Google Scholar
• CutlerAJMontgomerySAFeifelDLazarusAÅströmMBrecherMExtended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled studyJ Clin Psychiatry200970452653919358790
   PubMed Web of Science ®Google Scholar
• WeislerRJoyceMMcGillLLazarusASzamosiJErikssonHExtended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled studyCNS Spectr200914629931319668121
   PubMed Web of Science ®Google Scholar
• BauerMPretoriusHWConstantELEarleyWRSzamosiJBrecherMExtended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo- controlled, double-blind studyJ Clin Psychiatry200970454054919358791
   PubMed Web of Science ®Google Scholar
• El-KhaliliNJoyceMAtkinsonSExtended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled studyInt J Neuropsychopharmacol201013791793220175941
   PubMed Web of Science ®Google Scholar
• LiebowitzMLamRWLepolaUDattoCSweitzerDErikssonHEfficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trialDepress Anxiety2010271096497620734365
   PubMed Web of Science ®Google Scholar
• KatilaHMezhebovskyIMulroyARandomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorderAm J Geriatr Psychiatry201321817691784
   Web of Science ®Google Scholar
• GlickIDSuppesTDeBattistaCHuRJMarderSPsychopharmacologic treatment strategies for depression, bipolar disorder, and schizophreniaAnn Intern Med20011341476011187420
   PubMed Web of Science ®Google Scholar
• AstraZenecaEfficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder (AMBER) Available from: http://clinicaltrials.gov/ct2/show/NCT00351169. NLM identifier: NCT00351169Accessed November 18, 2013
   Google Scholar
• SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859Suppl 2022339881538
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• MontgomerySAÅsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• European Agency for the Evaluation of Medicinal ProductsCommittee for Proprietary Medicinal Products (CPMP): Note for guidance on clinical investigation of medicinal products in the treatment of depression2002 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003526.pdfAccessed November 6, 2013
   Google Scholar
• Forest PharmaceuticalsEscitalopram prescribing information2009 Available from: http://www.frx.com/pi/lexapro_pi.pdfAccessed November 6, 2013
   Google Scholar
• National Institute of Mental HealthCGI: clinical global impressionsGuyWBonatoRRManual for the ECDEU Assessment BatteryRockville (MD)NIMH197016
   Google Scholar
• HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508
   PubMed Web of Science ®Google Scholar
• EndicottJNeeJHarrisonWBlumenthalRQuality of Life Enjoyment and Satisfaction Questionnaire: a new measurePsychopharmacol Bull19932923213268290681
   PubMed Web of Science ®Google Scholar
• BuysseDJReynoldsCF3rdMonkTHBermanSRKupferDJThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchPsychiatry Res19892821932132748771
   PubMed Web of Science ®Google Scholar
• SimpsonGMAngusJWA rating scale for extrapyramidal side effectsActa Psychiatr Scand Suppl197021211194917967
   PubMedGoogle Scholar
• BarnesTRA rating scale for drug-induced akathisiaBr J Psychiatry19891546726762574607
   PubMed Web of Science ®Google Scholar
• ClaytonAHMcGarveyELClavetGJThe Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validityPsychopharmacol Bull19973347317459493486
   PubMed Web of Science ®Google Scholar
• MichelsonDFavaMAmsterdamJInterruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trialBr J Psychiatry200017636336810827885
   PubMed Web of Science ®Google Scholar
• RosenbaumJFFavaMHoogSLAscroftRCKrebsWBSelective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trialBiol Psychiatry199844277879646889
   PubMed Web of Science ®Google Scholar
• KhanASchwartzKStudy designs and outcomes in antidepressant clinical trialsEssent Psychopharmacol20056422122616041918
   PubMedGoogle Scholar
• YangHCusinCFavaMIs there a placebo problem in antidepressant trials?Curr Top Med Chem20055111077108616181132
   PubMed Web of Science ®Google Scholar
• FavaMEvinsAEDorerDJSchoenfeldDAThe problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approachPsychother Psychosom200372311512712707478
   PubMed Web of Science ®Google Scholar
• KobakKAKaneJMThaseMENierenbergAAWhy do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?J Clin Psychopharmacol20072711517224705
   PubMed Web of Science ®Google Scholar
• VietaEPappadopulosEMandelFSLombardoIImpact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled studyInt J Neuropsychopharmacol20111481017102721396153
   PubMed Web of Science ®Google Scholar
• DunlopBWThaseMEWunCCA meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sitesNeuropsychopharmacology201237132830283622910458
   PubMed Web of Science ®Google Scholar
• UndurragaJBaldessariniRJRandomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic reviewNeuropsychopharmacology201237485186422169941
   PubMed Web of Science ®Google Scholar
• YildizAVietaETohenMBaldessariniRJFactors modifying drug and placebo responses in randomized trials for bipolar maniaInt J Neuropsychopharmacol201114786387521299919
   PubMed Web of Science ®Google Scholar
• PapakostasGIFavaMDoes the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDDEur Neuropsychopharmacol2009191344018823760
   PubMed Web of Science ®Google Scholar
• PosternakMAZimmermanMKeitnerGIMillerIWA reevaluation of the exclusion criteria used in antidepressant efficacy trialsAm J Psychiatry2002159219120011823258
   PubMed Web of Science ®Google Scholar
• SteinDJBaldwinDSDolbergOTDespiegelNBandelowBWhich factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopramJ Clin Psychiatry200667111741174617196054
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationAntidepressant use in children, adolescents and adults2010 Available from: http://www.fda.gov/cder/drug/antidepressants/default.htmAccessed May 1, 2011
   Google Scholar
• American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of ObesityConsensus development conference on antipsychotic drugs and obesity and diabetesDiabetes Care200427259660114747245
   PubMed Web of Science ®Google Scholar